← SynDRA
TAFLUPROST
SynDRA canonical compound SYN0028811 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | PTGDR | PTGDR2 | PTGFR |
|---|
| Mechanism of action | prostaglandin inhibitor |
|---|
| Indication | glaucoma | ocular hypertension |
|---|
| Disease area | ophthalmology |
|---|
All known targets
Mechanisms of action (all sources)
- PTGFR AGONIST
- Prostanoid FP receptor agonist
- prostaglandin inhibitor
- PTGFR MODULATOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ACHE
- ADORA3
- SLC6A4
- SLC6A3
- SLC6A2
- PTGS1
- PGR
- PDE4A
- PDE3A
- OPRM1
- MAOA
- KDR
- KCNH2
- HTR2B
- HTR1A
- HRH3
- F2
- ESR1
- DRD3
- DRD1
- CHRM2
- CHRM1
- AR
- ADRA2A
- ADRA1A
- TBXA2R
Drug classes
- Prostaglandin Receptor Agonists
- Prostaglandin Analog
ATC classes
- S01E · ANTIGLAUCOMA PREPARATIONS AND MIOTICS
Cross-references
Synonyms
- ZIOPTAN
- Zioptan
- tafluprost ophthalmic solution
- zioptan
- taflotan
- tapros
- AFP-168
- MK-2452
- Saflutan
- Zioptan (TN)
- 1O6WQ6T7G3
- Taflotan
- CHEBI:66899
- MK2452
- tafluprostum
- tafluprost opthalmic
- Tafluprost Ophthalmic
- RefChem:57842
- S01EE05
- DTXCID601506522
- C25H34F2O5
- MFCD08062150
- Tapros
- Tafluprost?
- Tafluprost [INN]
- DE-085
- TAFLUPROST [MI]
- TAFLUPROST [JAN]
- TAFLUPROST [USAN]
- TAFLUPROST [VANDF]
- TAFLUPROST [MART.]
- TAFLUPROST [WHO-DD]
- UNII-1O6WQ6T7G3
- Tafluprost (JAN/USAN/INN)
- Tafluprost [USAN:INN:BAN]
- GTPL7451
- SCHEMBL1286148
Reported adverse events
Look up TAFLUPROST in the interactive SynDRA portal →